Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels

Journal of Lipid Research

Volumn 42, Issue 5, 2001, Pages 844-855

  Ko, Carol ^a   Lee, Tsai Ling ^a   Lau, Philip W ^a   Li, Jing ^a   Davis, Brandi T ^a   Voyiaziakis, Emanuel ^a   Allison, David B ^a,b   Chua Jr , Streamson C ^a,b   Huang, Li Shin ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

ApoB secretion; Familial combined hyperlipidemia; Genetics; Hypobetalipoproteinemia; Inbred mouse strains; Mapping

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME MAP; CONTROLLED STUDY; CORRELATION FUNCTION; EPISTASIS; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HYPOBETALIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE TRAIT; REGULATOR GENE; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS B; CHROMOSOMES; EPISTASIS, GENETIC; FEMALE; HUMANS; LINKAGE (GENETICS); LIVER; LOD SCORE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE; VARIATION (GENETICS);

EID: 0034980519     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Association of coronary atherosclerosis with hyperapobetalipoproteinemia
2. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins
3. Apolipoprotein B messenger RNA editing: Insights into the molecular regulation of post-transcriptional cytidine deamination
4. Known mutations of apoB account for only a small minority of hypobetalipoproteinemia
5. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene
6. Novel genes for familial combined hyperlipidemia
7. Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia
8. Major locus inheritance of apolipoprotein B in Utah pedigrees
9. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: The Bogalusa Heart Study
10. Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic
11. Familial resemblance of plasma apolipoprotein B: The Nancy Study
12. Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
13. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice
14. Overview of QTL mapping software and introduction to map manager QT
15. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
16. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles
17. Molecular characterization of a novel human gene, SEC13R, related to the yeast secretory pathway gene SEC13, and mapping to a conserved linkage group on human chromosome 3p24-p25 and mouse chromosome 6
18. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping
19. Assignment of the gene encoding the human apolipoprotein B mRNA editing enzyme (APOBEC1) to chromosome 12p13.1
20. Genetic factors controlling structure and expression of apolipoproteins B and E in mice
21. COP11: A membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum
22. Intracellular degradation of newly synthesized apolipoprotein B
23. ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins
24. Peroxisome proliferator-activated receptor gamma and the control of adipogenesis
25. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation
26. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
27. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
28. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
29. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency
30. Apolipoprotein B mRNA editing: A key controlling element targeting fats to proper tissue
31. A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene
32. Genetic heterogeneity in familial hypobetalipoproteinemia: Linkage and non-linkage to the apoB gene in Caucasian families
33. Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22
34. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred
35. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32
36. Genetic localization to chromosome lp32 of the third locus for familial hypercholesterolemia in a Utah kindred
37. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
38. Kinetic bases of the primary hyperlipidaemias: Studies of apolipoprotein B turnover in genetically defined subjects
39. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: Implications for the pathophysiology of apoB production
40. Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver
41. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia
42. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
43. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
44. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome ll
45. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels
46. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells
47. Statins: Within-group comparisons, statin escape and combination therapy